Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07893171) titled 'Study of CM529D1 in Participants With Advanced Solid Tumors' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Keymed Biosciences Co.Ltd
Condition:
Advanced Solid Tumors
Intervention:
Biological: CM529D1
Biological: CM529D1
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: November 27, 2026
Target Sample Size: 128
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07893171
Disclaimer: Cura...